Developing countries need biotechnology products and must pay for what is used. At the same time developing countries take out patents on their own genetic materials, largely unimproved germplasm. However, we do not presently have a real market for these materials/technologies, a market which operates efficiently as do markets for major agricultural commodities. Principal limitations, in my viewpoint, are the weakness/lack of Intellectual Property Rights in many recipient countries and the virtual absence of laws controlling access to genetic materials.
Agricutural biotechnology; public good; deloping nations; technology transfer; government regulation; global population;